BACKGROUND: Colorectal cancer (CRC) screening is cost-effective but underused. The objective of this study was to determine the cost-effectiveness of a mailed standard intervention (SI) and tailored navigation interventions (TNIs) to increase CRC screening use in the context of a randomized trial among primary care patients. METHODS:Participants (n = 945) were randomized either to a usual care control group (n = 317), to an SI group (n = 316), or to a TNI group (n = 312). The SI group was sent both colonoscopy instructions and stool blood tests irrespective of baseline preference. TNI group participants were sent instructions for scheduling a colonoscopy, a stool blood test, or both based on their test preference, as determined at baseline; then, they received a navigation telephone call. Activity cost estimation was used to determine the cost of each intervention and to compute incremental cost-effectiveness ratios. Statistical uncertainty within the base case was assessed with 95% confidence intervals derived from net benefit regression analysis. The effects of uncertain parameters, such as the cost of planning, training, and involvement of those receiving "investigator salaries," were assessed with sensitivity analyses. RESULTS:Program costs of the SI were $167 per participant. The average cost of the TNI was $289 per participant. CONCLUSIONS: The TNI was more effective than the SI but substantially increased the cost per additional individual screened. Decision-makers need to consider cost structure, level of planning, and training required to implement these 2 intervention strategies and their willingness to pay for additional individuals screened to determine whether a tailored navigation would be justified and feasible.
RCT Entities:
BACKGROUND:Colorectal cancer (CRC) screening is cost-effective but underused. The objective of this study was to determine the cost-effectiveness of a mailed standard intervention (SI) and tailored navigation interventions (TNIs) to increase CRC screening use in the context of a randomized trial among primary care patients. METHODS:Participants (n = 945) were randomized either to a usual care control group (n = 317), to an SI group (n = 316), or to a TNI group (n = 312). The SI group was sent both colonoscopy instructions and stool blood tests irrespective of baseline preference. TNI group participants were sent instructions for scheduling a colonoscopy, a stool blood test, or both based on their test preference, as determined at baseline; then, they received a navigation telephone call. Activity cost estimation was used to determine the cost of each intervention and to compute incremental cost-effectiveness ratios. Statistical uncertainty within the base case was assessed with 95% confidence intervals derived from net benefit regression analysis. The effects of uncertain parameters, such as the cost of planning, training, and involvement of those receiving "investigator salaries," were assessed with sensitivity analyses. RESULTS: Program costs of the SI were $167 per participant. The average cost of the TNI was $289 per participant. CONCLUSIONS: The TNI was more effective than the SI but substantially increased the cost per additional individual screened. Decision-makers need to consider cost structure, level of planning, and training required to implement these 2 intervention strategies and their willingness to pay for additional individuals screened to determine whether a tailored navigation would be justified and feasible.
Authors: G Abuksis; M Mor; N Segal; I Shemesh; I Morad; S Plaut; E Weiss; J Sulkes; G Fraser; Y Niv Journal: Am J Gastroenterol Date: 2001-06 Impact factor: 10.864
Authors: M Baier; N Calonge; G Cutter; M McClatchey; S Schoentgen; S Hines; A Marcus; D Ahnen Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-02 Impact factor: 4.254
Authors: Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender Journal: Cancer Date: 2007-11-01 Impact factor: 6.860
Authors: David R Lairson; Melissa DiCarlo; Ronald E Myers; Thomas Wolf; James Cocroft; Randa Sifri; Michael Rosenthal; Sally W Vernon; Richard Wender Journal: Cancer Date: 2008-02-15 Impact factor: 6.860
Authors: Ronald E Myers; Terry Hyslop; Randa Sifri; Heather Bittner-Fagan; Nora C Katurakes; James Cocroft; Melissa Dicarlo; Thomas Wolf Journal: Med Care Date: 2008-09 Impact factor: 2.983
Authors: Karen E Lasser; Jennifer Murillo; Elizabeth Medlin; Sandra Lisboa; Lisa Valley-Shah; Robert H Fletcher; Karen M Emmons; John Z Ayanian Journal: BMC Fam Pract Date: 2009-05-29 Impact factor: 2.497
Authors: Richard T Meenan; Melissa L Anderson; Jessica Chubak; Sally W Vernon; Sharon Fuller; Ching-Yun Wang; Beverly B Green Journal: Am J Prev Med Date: 2015-06 Impact factor: 5.043
Authors: Melinda M Davis; Siddhartha Nambiar; Maria E Mayorga; Eliana Sullivan; Karen Hicklin; Meghan C O'Leary; Kristen Dillon; Kristen Hassmiller Lich; Yifan Gu; Bonnie K Lind; Stephanie B Wheeler Journal: Prev Med Date: 2019-10-18 Impact factor: 4.018
Authors: Shivan J Mehta; Tanya Khan; Carmen Guerra; Catherine Reitz; Timothy McAuliffe; Kevin G Volpp; David A Asch; Chyke A Doubeni Journal: Am J Gastroenterol Date: 2018-12 Impact factor: 10.864
Authors: Karen E Kim; Fornessa Randal; Matt Johnson; Michael Quinn; Chieko Maene; Sonja Hoover; Valerie Richmond-Reese; Florence K L Tangka; Djenaba A Joseph; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860
Authors: Christen L Lara; Kelly L Means; Krystal D Morwood; Westley R Lighthall; Sonja Hoover; Florence K L Tangka; Cynthia French; Krystal D Gayle; Amy DeGroff; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860
Authors: Giridhar Mohan; Sajal K Chattopadhyay; Donatus U Ekwueme; Susan A Sabatino; Devon L Okasako-Schmucker; Yinan Peng; Shawna L Mercer; Anilkrishna B Thota Journal: Am J Prev Med Date: 2019-08-30 Impact factor: 5.043